An announcement from Beijing Tong Ren Tang Chinese Medicine Co ( (HK:3613) ) is now available.
The company has announced the composition of its board of directors and their roles, highlighting the leadership structure with Gu Hai Ou as Chairman and Wang Chi as CEO. This announcement provides clarity on the governance framework, which could impact the company’s strategic direction and reassure stakeholders about its management stability.
More about Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Co is a company incorporated in Hong Kong, operating in the traditional Chinese medicine industry. It focuses on producing and distributing Chinese medicinal products and services, catering to a market that values traditional health remedies.
YTD Price Performance: -0.31%
Technical Sentiment Signal: Buy
Current Market Cap: $933.3M
Find detailed analytics on 3613 stock on TipRanks’ Stock Analysis page.